BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 37889101)

  • 1. Exosomal lncRNA NEAT1 Inhibits NK-Cell Activity to Promote Multiple Myeloma Cell Immune Escape via an EZH2/PBX1 Axis.
    Wang QM; Lian GY; Sheng SM; Xu J; Ye LL; Min C; Guo SF
    Mol Cancer Res; 2024 Feb; 22(2):125-136. PubMed ID: 37889101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exosomal lncRNA NEAT1 from cancer-associated fibroblasts facilitates endometrial cancer progression via miR-26a/b-5p-mediated STAT3/YKL-40 signaling pathway.
    Fan JT; Zhou ZY; Luo YL; Luo Q; Chen SB; Zhao JC; Chen QR
    Neoplasia; 2021 Jul; 23(7):692-703. PubMed ID: 34153644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of long noncoding RNA
    Chen T; Sun Z; Cui Y; Ji J; Li Y; Qu X
    Hematology; 2023 Dec; 28(1):2164449. PubMed ID: 36657019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exosomal lncRNA Nuclear Paraspeckle Assembly Transcript 1 (NEAT1)contributes to the progression of allergic rhinitis via modulating microRNA-511/Nuclear Receptor Subfamily 4 Group A Member 2 (NR4A2) axis.
    Wang T; Cai W; Wu Q; Chen D; Wang P; Xu Z
    Bioengineered; 2021 Dec; 12(1):8067-8079. PubMed ID: 34672863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of m
    Wang Z; He J; Bach DH; Huang YH; Li Z; Liu H; Lin P; Yang J
    J Exp Clin Cancer Res; 2022 Jan; 41(1):4. PubMed ID: 34980213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA NEAT1 promotes endometrial cancer cell proliferation, migration and invasion by regulating the miR-144-3p/EZH2 axis.
    Wang W; Ge L; Xu XJ; Yang T; Yuan Y; Ma XL; Zhang XH
    Radiol Oncol; 2019 Nov; 53(4):434-442. PubMed ID: 31747378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exosomal long noncoding RNA MLETA1 promotes tumor progression and metastasis by regulating the miR-186-5p/EGFR and miR-497-5p/IGF1R axes in non-small cell lung cancer.
    Hsu XR; Wu JE; Wu YY; Hsiao SY; Liang JL; Wu YJ; Tung CH; Huang MF; Lin MS; Yang PC; Chen YL; Hong TM
    J Exp Clin Cancer Res; 2023 Oct; 42(1):283. PubMed ID: 37880793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exosome-transmitted lncRNA UFC1 promotes non-small-cell lung cancer progression by EZH2-mediated epigenetic silencing of PTEN expression.
    Zang X; Gu J; Zhang J; Shi H; Hou S; Xu X; Chen Y; Zhang Y; Mao F; Qian H; Zhu T; Xu W; Zhang X
    Cell Death Dis; 2020 Apr; 11(4):215. PubMed ID: 32242003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosomal lncRNA SNHG10 derived from colorectal cancer cells suppresses natural killer cell cytotoxicity by upregulating INHBC.
    Huang Y; Luo Y; Ou W; Wang Y; Dong D; Peng X; Luo Y
    Cancer Cell Int; 2021 Oct; 21(1):528. PubMed ID: 34641864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silencing long noncoding RNA NEAT1 alleviates acute liver failure via the EZH2-mediated microRNA-139/PUMA axis.
    Wang Q; Liu S; Wang H; Liu L; Zhang S; Ming Y; Zhao Y; Cheng K
    Aging (Albany NY); 2021 Apr; 13(9):12537-12551. PubMed ID: 33901015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer cell-derived exosomal circUHRF1 induces natural killer cell exhaustion and may cause resistance to anti-PD1 therapy in hepatocellular carcinoma.
    Zhang PF; Gao C; Huang XY; Lu JC; Guo XJ; Shi GM; Cai JB; Ke AW
    Mol Cancer; 2020 Jun; 19(1):110. PubMed ID: 32593303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-chain polyunsaturated omega-3 fatty acids reduce multiple myeloma exosome-mediated suppression of NK cell cytotoxicity.
    Moloudizargari M; Redegeld F; Asghari MH; Mosaffa N; Mortaz E
    Daru; 2020 Dec; 28(2):647-659. PubMed ID: 32974883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal stem cell-derived exosomal microRNA-133b suppresses glioma progression via Wnt/β-catenin signaling pathway by targeting EZH2.
    Xu H; Zhao G; Zhang Y; Jiang H; Wang W; Zhao D; Hong J; Yu H; Qi L
    Stem Cell Res Ther; 2019 Dec; 10(1):381. PubMed ID: 31842978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The long non-coding RNA NEAT1 interacted with miR-101 modulates breast cancer growth by targeting EZH2.
    Qian K; Liu G; Tang Z; Hu Y; Fang Y; Chen Z; Xu X
    Arch Biochem Biophys; 2017 Feb; 615():1-9. PubMed ID: 28034643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long Noncoding RNA NEAT1 Promotes Growth and Metastasis of Cholangiocarcinoma Cells.
    Zhang C; Li JY; Tian FZ; Zhao G; Hu H; Ma YF; Yang YL
    Oncol Res; 2018 Jul; 26(6):879-888. PubMed ID: 28810932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural Killer Cell Phenotype and Functionality Affected by Exposure to Extracellular Survivin and Lymphoma-Derived Exosomes.
    Ferguson Bennit HR; Gonda A; Kabagwira J; Oppegard L; Chi D; Licero Campbell J; De Leon M; Wall NR
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33513976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BMSC-derived exosomal lncRNA PTENP1 suppresses the malignant phenotypes of bladder cancer by upregulating SCARA5 expression.
    Liu SC; Cao YH; Chen LB; Kang R; Huang ZX; Lu XS
    Cancer Biol Ther; 2022 Dec; 23(1):1-13. PubMed ID: 35998226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long noncoding RNA NEAT1 suppresses hepatocyte proliferation in fulminant hepatic failure through increased recruitment of EZH2 to the LATS2 promoter region and promotion of H3K27me3 methylation.
    Wang Q; Liu L; Zhang S; Ming Y; Liu S; Cheng K; Zhao Y
    Exp Mol Med; 2020 Mar; 52(3):461-472. PubMed ID: 32157157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural Killer-Derived Exosomal miR-186 Inhibits Neuroblastoma Growth and Immune Escape Mechanisms.
    Neviani P; Wise PM; Murtadha M; Liu CW; Wu CH; Jong AY; Seeger RC; Fabbri M
    Cancer Res; 2019 Mar; 79(6):1151-1164. PubMed ID: 30541743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy-elicited exosomal miR-378a-3p and miR-378d promote breast cancer stemness and chemoresistance via the activation of EZH2/STAT3 signaling.
    Yang Q; Zhao S; Shi Z; Cao L; Liu J; Pan T; Zhou D; Zhang J
    J Exp Clin Cancer Res; 2021 Apr; 40(1):120. PubMed ID: 33823894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.